Aspirin prevents venous thromboembolism following major orthopedic surgeries, study finds

March 13, 2018 by Tod Hoffman, McGill University
Credit: CC0 Public Domain

A multicentre, double-blind, randomized, controlled clinical trial of patients who underwent total hip or knee replacement surgery showed that aspirin was as effective as rivaroxaban, the standard anti-coagulation medication, at preventing post-operative venous thromboembolism (VTE). Montreal's Jewish General Hospital (JGH) was among the participating institutions. The results were published in the New England Journal of Medicine.

"We have always been very concerned about preventing in following major orthopedic surgery," said Dr. David Zukor, chief of orthopedics at the JGH and one of authors of the study. "It is the leading cause of preventable in-hospital death, so we always administer preventive therapy in conjunction with such surgeries. Rivaroxaban is known to be effective, but the great advantage of aspirin is that it is far less expensive, easily available, and has an excellent safety profile."

All 3424 patients enrolled in the trial (1804 for hip replacement and 1620 for knee replacement) took rivaroxaban for five days after surgery before being randomized either to receive aspirin (1707 patients) or to continue with rivaroxaban (1717 patients). Eleven in the former group and 12 in the latter experienced VTE. The most worrisome complication from anti-coagulants is bleeding. In this trial, rates of clinically important bleeding were less than 1.5% and did not differ significantly between the two groups. All bleeding events occurred at the surgical site, as opposed to other, potentially more dangerous, regions such as the brain or gastrointestinal tract.

"These results are important," asserted Dr. Susan Kahn, Director of the Centre for Excellence in Thrombosis and Anticoagulation Care at the JGH and a leading expert on VTE, who was also a researcher on the study. "The protocols for preventing clots following major orthopedic surgery are well established. However, we are always interested in determining whether there are better options for treating our patients. We could well see aspirin emerge as a practical alternative to more expensive anticoagulants."

Both Drs. Kahn and Zukor agree on the need for additional clinical that would see a randomized group of patients prescribed aspirin exclusively as a preventative, so as to test its efficacy directly against a regimen of .

During the course of the trial, all patients undergoing hip or at the JGH were offered the opportunity to participate.

Explore further: New blood thinner better at preventing recurrent blood clots than aspirin

More information: David R. Anderson et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty, New England Journal of Medicine (2018). DOI: 10.1056/NEJMoa1712746

Related Stories

New blood thinner better at preventing recurrent blood clots than aspirin

March 19, 2017
An international research team with prominent Canadian leadership has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of life-threatening blood clots in the legs ...

Drug stops dangerous bleeding in patients taking factor Xa inhibitors

March 12, 2018
The experimental drug andexanet was associated with control of serious bleeding in patients taking a common class of anticoagulants known as Factor Xa inhibitors, according to interim clinical trial results presented at the ...

Blood thinner and aspirin show similar bleeding risk in coronary patients

March 20, 2017
Substituting rivaroxaban for aspirin in patients with acute coronary syndromes (ACS) appears to cause no significant increase in bleeding risk, according to a study led by scientists from the Duke Clinical Research Institute ...

Rivaroxaban reduces VTE recurrence compared with aspirin

March 20, 2017
In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning medication rivaroxaban reduced recurrences more than three-fold compared with aspirin, with ...

No increase in bleeding complications with rivaroxaban post-ACS

March 20, 2017
Patients with acute coronary syndrome who were treated with the blood-thinning drug rivaroxaban in addition to an antiplatelet medication (clopidogrel or ticagrelor) experienced no increase in bleeding complications compared ...

Best anticoagulants after orthopedic procedures depends on type of surgery

July 17, 2014
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up to individual clinicians. ...

Recommended for you

Effective drug delivery to heart with tannic acid

September 18, 2018
Typical methods of drug delivery to the heart require surgical procedures involving incisions in the chest wall and bones. To efficiently treat cardiovascular and related vascular diseases without surgery, a KAIST research ...

Daily low-dose aspirin found to have no effect on healthy life span in older people

September 16, 2018
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia ...

Financial incentives for cholesterol control may be cost-effective

September 14, 2018
A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease ...

Apple's smartwatch has a heart monitor now

September 13, 2018
There will soon be another way to monitor your heart—from your wrist.

3-D virtual simulation gets to the 'heart' of irregular heartbeats

September 12, 2018
In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3-D personalized virtual simulations of the heart to accurately identify where cardiac specialists should electrically destroy ...

Dairy consumption linked to lower rates of cardiovascular disease and mortality

September 12, 2018
Dairy consumption of around three servings per day is associated with lower rates of cardiovascular disease and mortality, compared to lower levels of consumption, according to a global observational study of over 130,000 ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.